Abdul Wasay Mahmood

Roswell Park Comprehensive Cancer Center

Papers

5

Total Citations

16

H-Index

3

About

Abdul Wasay Mahmood is a leading urologic oncology researcher whose work centers on optimizing surgical outcomes for patients undergoing robot-assisted radical cystectomy (RARC) for bladder cancer. His major contributions focus on reducing postoperative complications, particularly urinary tract infections and ureteroenteric strictures. Through randomized controlled trials and large retrospective analyses, he has investigated whether prophylactic antibiotics can lower UTI rates after RARC and whether stent-free ureteroenteric anastomosis reduces stricture formation—findings that directly shape clinical protocols. Mahmood’s research also explores oncological outcomes, including the impact of neoadjuvant chemotherapy for variant histology bladder cancer and the prognostic significance of tumor involvement in the trigone and urethra. His work, drawing on multi-institutional databases like the International Robotic Cystectomy Consortium, has garnered citations across several high-impact papers published in 2024–2025. By addressing both technical refinements and oncological risk factors, Mahmood’s research provides actionable insights for surgeons and improves long-term outcomes for patients undergoing robotic cystectomy.

Research Focus

Key Achievements

3
H-Index
5
Papers
16
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Do Prophylactic Antibiotics Decrease the Rate of Urinary Tract Infections After Robot-Assisted Radical Cystectomy? A Randomized Controlled Trial
4 citations · 2025
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Roswell Park Comprehensive Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago